Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
- Status
- RECRUITING
- Phase
- N/A
Classifying for HER2 Dependence to De-Escalate Neoadjuvant Chemotherapy in Patients With HER2+ Early Breast Cancer Undergoing HER2 Double-Blockade
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pyrotinib Plus Capecitabine for Adjuvant Treatment of HER2 Positive Early-stage Breast Cancer
- Status
- RECRUITING
- Phase
- N/A
Tucatinib, Trastuzumab and Capecitabine With Brain and/or Spinal Radiotherapy (XRT) in Patients With HER2+, HER2 Mutated and/or HER2-amplified Metastatic Breast Cancer and Leptomeningeal Disease: A Multi-centre Phase II, Single Arm Feasibility Study
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE3
Basket Study for Oligo-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- NA
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- COMPLETED
- Phase
- NA
Exosome as the Prognostic and Predictive Biomarker in EBC Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Tucatinib in Combination With Oral Etoposide andTrastuzumab in Patients With Metastatic HER2+ Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BC
- Status
- UNKNOWN
- Phase
- PHASE2
Comparing the Efficacy of Nab-PH+Pyrrolitinib and TCbHP in the Neoadjuvant Treatment of HER2 Positive BC
- Status
- RECRUITING
- Phase
- PHASE2
Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Safety of Withdrawal of Pharmacological Treatment for Recovered HER2 Targeted Therapy Related Cardiac Dysfunction
- Status
- RECRUITING
- Phase
- NA
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
Pyrotinib in Women With High-risk in Early Stage Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2